| References: |
Description of CI-1040: CI-1040 is a MEK inhibitor, which demonstrated in vivo activity in preclinical animal models and subsequently became the first MEK inhibitor to enter clinical trial. CI-1040 suffered however from poor exposure due to its poor solubility and rapid clearance, and as a result, development of the compound was terminated.
For the detailed information about the solubility of CI-1040 (PD184352) in water, the solubility of CI-1040 (PD184352) in DMSO, the solubility of CI-1040 (PD184352) in PBS buffer, the animal experiment（test） of CI-1040 (PD184352),the in vivo,in vitro and clinical trial test of CI-1040 (PD184352),the cell experiment（test） of CI-1040 (PD184352),the IC50, EC50 and Affinity of CI-1040 (PD184352), please contact DC Chemicals. |
